Coya Therapeutics Inc
COYA
Get informed when a big investor buys or sells
+ FollowMarket Cap$102.74M
Close$
$-0.12
102.9% downside
Current Fair Value
102.9% downsideOvervalued by 102.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $102.74 Million |
|---|---|
| Enterprise Value | $-41,844,807,534.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.27 |
| Beta | 0.62 |
| Outstanding Shares | 23,457,227 |
Return
| Return on Equity | -4.93% |
|---|---|
| Return on Assets | -4.51% |
| Return on Invested Capital | -4.87% |
Valuation & Multiples
| P/E Ratio | -4.09 |
|---|---|
| PEG | 4.1 |
| Price to Sales | 0.03 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -11.73 |
| Enterprise Value to EBIT | 19.6 |
| Enterprise Value to Net Income | 19 |
| Total Debt to Enterprise | -0.03 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.42
Average shareholder expectationRevenue Estimate
$150,000
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$110,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 58,900▼ 7.10% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 33.22%▼ 2.69% |
|---|---|
| Total Invested | $45.55M▲ 42.13% |
| Investors Holding | 57▼ 1.00% |
ESG Score
No data